
FDA panel recommends Pfizer COVID-19 vaccine for kids 5-11
The vaccines advisory committee to the Food and Drug Administration voted on Tuesday to recommend that Pfizer’s COVID-19 vaccine be approved for children between 5 and 11 years old. The Vaccines and Related Biological Products Advisory Committee